A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin

Ildiko Lingvay; Cyrus V. Desouza; Katarina S. Lalic; Ludger Rose; Thomas Hansen; Jeppe Zacho; Thomas R. Pieber

doi:10.2337/dc17-2381

A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin

Diabetes Care ◽

10.2337/dc17-2381 ◽

2018 ◽

Vol 41 (9) ◽

pp. 1926-1937 ◽

Cited By ~ 17

Author(s):

Ildiko Lingvay ◽

Cyrus V. Desouza ◽

Katarina S. Lalic ◽

Ludger Rose ◽

Thomas Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Once Daily ◽

Randomized Controlled ◽

Diet And Exercise

Download Full-text

Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes

Diabetic Medicine ◽

10.1111/dme.12828 ◽

2015 ◽

Vol 33 (2) ◽

pp. 224-230 ◽

Cited By ~ 36

Author(s):

M. A. Bethel ◽

P. Harrison ◽

H. Sourij ◽

Y. Sun ◽

L. Tucker ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Platelet Reactivity ◽

Controlled Trial ◽

Once Daily ◽

Randomized Controlled ◽

Daily Aspirin

Download Full-text

A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once-daily injection in patients with well-controlled type 2 diabetes

The Journal of Clinical Pharmacology ◽

10.1002/jcph.483 ◽

2015 ◽

Vol 55 (7) ◽

pp. 831-838 ◽

Cited By ~ 2

Author(s):

Yuichiro Inoue ◽

Akinobu Nakamura ◽

Yoshinobu Kondo ◽

Kumiko Hamano ◽

Shinobu Satoh ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Insulin Detemir ◽

Controlled Trial ◽

Daily Injection ◽

Once Daily ◽

Randomized Controlled

Download Full-text

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2008.03.018 ◽

2008 ◽

Vol 81 (2) ◽

pp. 161-168 ◽

Cited By ~ 79

Author(s):

Y. Seino ◽

M.F. Rasmussen ◽

M. Zdravkovic ◽

K. Kaku

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Weight Gain ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Once Daily ◽

Randomized Controlled ◽

Dose Dependent

Download Full-text

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0163350 ◽

2016 ◽

Vol 11 (10) ◽

pp. e0163350 ◽

Cited By ~ 13

Author(s):

Ajay Kumar ◽

Edward Franek ◽

Jonathan Wise ◽

Marcus Niemeyer ◽

Henriette Mersebach ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Insulin Aspart ◽

Controlled Trial ◽

Insulin Degludec ◽

Efficacy And Safety ◽

Once Daily ◽

Randomized Controlled

Download Full-text

Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

Diabetes & Metabolism Journal ◽

10.4093/dmj.2019.0093 ◽

2020 ◽

Vol 44 (4) ◽

pp. 532 ◽

Cited By ~ 1

Author(s):

Kyu Yong Cho ◽

Akinobu Nakamura ◽

Chiho Oba-Yamamoto ◽

Kazuhisa Tsuchida ◽

Shingo Yanagiya ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Insulin Degludec ◽

Once Daily ◽

Postprandial Glycemia ◽

Randomized Controlled

Download Full-text

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc20-2877 ◽

2021 ◽

pp. dc202877

Author(s):

Harpreet S. Bajaj ◽

Richard M. Bergenstal ◽

Andreas Christoffersen ◽

Melanie J. Davies ◽

Amoolya Gowda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Basal Insulin ◽

Controlled Trial ◽

Phase 2 ◽

Once Daily ◽

Randomized Controlled ◽

Daily Insulin

Download Full-text

Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211): A 12-week, double-blind, randomized, controlled trial

Diabetes Care ◽

10.2337/diacare.27.6.1335 ◽

2004 ◽

Vol 27 (6) ◽

pp. 1335-1342 ◽

Cited By ~ 218

Author(s):

S. Madsbad ◽

O. Schmitz ◽

J. Ranstam ◽

G. Jakobsen ◽

D. R. Matthews

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Double Blind ◽

Once Daily ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Download Full-text

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc18-0680 ◽

2018 ◽

Vol 41 (10) ◽

pp. 2136-2146 ◽

Cited By ~ 38

Author(s):

Serge A. Jabbour ◽

Juan P. Frías ◽

Elise Hardy ◽

Azazuddin Ahmed ◽

Hui Wang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Once Daily ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Metformin Monotherapy

Download Full-text

Intervention of the Flash Glucose Sensing Technology on Glycemic Control and Treatment Satisfaction in Patients with Type 2 Diabetes Treated Intensively by Insulin—A Randomized Controlled Trial

Diabetes ◽

10.2337/db18-908-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 908-P ◽

Cited By ~ 1

Author(s):

MARIANNA YARON ◽

EYTAN ROITMAN ◽

GENYA AHARON-HANANEL ◽

ZOHAR LANDAU ◽

TALI GANZ ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Glycemic Control ◽

Treatment Satisfaction ◽

Controlled Trial ◽

Glucose Sensing ◽

Randomized Controlled ◽

Sensing Technology

Download Full-text

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text